Spotlight on JLABS

Sep 6 2017

Interested in starting a company, investing, or just curious about the current state of innovation in San Diego? Then YOU are invited to JLABS on September 6th to meet, greet, and see short presentations on some of our standout companies. Space is limited, so don't miss out!

Did you know that JLABS San Diego is home to nearly 50 emerging companies? On September 6th, JLABS will shine the spotlight on four of our resident companies: AimRx, Chime, and Lin Bioscience. Join us to see how they're moving innovation forward, right here in San Diego.

Please note that the presentations at this event will include publicly available, non-confidential information only.

Wednesday, September 6, 2017

11:30am | Lunch
12:00pm | Presentations
1:00pm | Program Close

Presenting Companies:
Chime read more»
AimRx / EpicentRx read more»
Lin Bioscience read more»

Please RSVP online so that we can get an accurate headcount for food and beverages. We will not be accepting walk-ups once the event is sold out.

3210 Merryfield Row
San Diego, CA

Presenting Companies' Descriptions:

CHIME BioTherapeutics, Inc. is an immuno-oncology company focused on the development of innovative cancer immunotherapies based on the breakthrough concept of recalling and harnessing pre-existing memory immunity from childhood vaccines to treat a variety of cancers. CHIME BTx is the first corporate spin-off from La Jolla Institute for Allergy and Immunology (LJI, San Diego) in over 25 years. CHIME has obtained an exclusive license to specific intellectual property from LJI."

AimRX / EpicentRx
AIMRx / EpicentRx, a clinical stage biotechnology company, is at the forefront of the rapidly emerging field of epigenetics and has the potential to change the face of medicine. With a focus on the epicenter of life science innovation and forward-thinking leadership, EpicentRx embodies a “radical” new approach to discover and develop improved therapeutic options from non-traditional sources for unmet medical needs.

Lin Bioscience
Lin BioScience is a biotechnology company that specializes in new drug development for innovative therapeutics in diseases with unmet medical needs. Lin BioScience’s diverse and novel pipelines consist of first-in-class drug candidates aiming to treat life-threatening or disabling diseases in Oncology and Ophthalmology indications.